AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glimican-M2 Tablet PR

Prescription Icon
Prescription Required

Marketer

Alican Pharmaceutical Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimican-M2 Tablet PR

DiabetaComb-Duo tablets are a dual-action antidiabetic medication, combining two agents to manage type 2 diabetes in adults. This medication helps regulate blood glucose. DiabetaComb-Duo should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar readings. Continued use is crucial, even with well-controlled blood sugar, as discontinuation without medical supervision can lead to elevated glucose levels, increasing the risk of complications like kidney damage, vision impairment, neuropathy, and limb loss. This medication is just one component of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headaches, and tremors. Recognize these symptoms and know how to counter them with readily available glucose, such as sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. DiabetaComb-Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Inform your doctor of any history of heart problems before starting this medication, as it may not be appropriate. Pregnant or breastfeeding individuals should consult their physician before use. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.

Uses of Glimican-M2 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimican-M2 Tablet PR:

Follow your doctor's instructions or the package directions before taking Glimican-M2 Tablet PR. This medication should be administered with food.

Common Side effects of Glimican-M2 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimican-M2 Tablet PR:

Follow your physician's guidance or consult the product information for usage instructions. Administer Glimican-M2 Tablet PR with a meal.

How Glimican-M2 Tablet PR works:

Glimican-M2 Tablet PR combines glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimican-M2 Tablet PR with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimican-M2 Tablet PR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Glimican-M2 Tablet PR. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimican-M2 Tablet PR, as dose modification may be necessary. Consult your physician for guidance. Glimican-M2 Tablet PR is contraindicated in individuals with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimican-M2 Tablet PR cautiously, potentially requiring dosage modification. A physician's consultation is recommended. For those with mild to moderate liver disease, Glimican-M2 Tablet PR should typically commence at a low dose; its use is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimican-M2 Tablet PR :

Should you forget a Glimican-M2 Tablet PR dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About Glimican-M2 Tablet PR

LabelValue
Potential for Dependence None.
Medication Classification Diabetes medication

FAQs on Glimican-M2 Tablet PR

Maintain this medication within its original, sealed container or packaging. Follow the storage guidelines printed on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and others.
Glimican-M2 Tablet PR can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse reaction is particularly risky for individuals with kidney impairment, the elderly, or those who consume significant alcohol. Symptoms may encompass muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Glimican-M2 Tablet PR use and seek immediate medical attention.
Glimican-M2 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with a suitable diet and exercise regimen. Glimepiride stimulates pancreatic insulin release, thereby reducing blood glucose. Metformin acts by decreasing hepatic glucose production and improving insulin responsiveness. This formulation is unsuitable for treating type 1 DM.
Glimican-M2 Tablet PR may cause common adverse reactions including hypoglycemia, altered taste perception, nausea, abdominal discomfort, diarrhea, and headache. Rare but potentially serious side effects such as lactic acidosis can also occur. Prolonged use might result in vitamin B12 deficiency.
Prolonged Glimican-M2 Tablet PR use can indeed lead to Vitamin B12 deficiency by hindering its gastrointestinal absorption. This deficiency, if left unaddressed, may result in anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and ataxia. To mitigate these risks, supplemental Vitamin B12 is recommended annually by some experts.
Indeed, Glimican-M2 Tablet PR can induce hypoglycemia. Manifestations of low blood sugar include nausea, headache, irritability, hunger pangs, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. These symptoms are exacerbated by skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Glimican-M2 Tablet PR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia). Alcohol use also raises the likelihood of lactic acidosis.
Glimican-M2 Tablet PR
59
MRP 72
17% off